Screener
Artiva Biotherapeutics, Inc. ARTV Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Artiva Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
FAQ
- What is Artiva Biotherapeutics, Inc.'s current ratio?
- Artiva Biotherapeutics, Inc. (ARTV) reported current ratio of 24.2× in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s current ratio changed year-over-year?
- Artiva Biotherapeutics, Inc.'s current ratio increased by 74.5% year-over-year, from 13.8× to 24.2×.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s current ratio?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s current ratio has grown at a 14.8% compound annual growth rate (CAGR), from 6.5× to 8.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Artiva Biotherapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude